Literature DB >> 29695388

Hypomorphic citrullinaemia due to mutated ASS1 with episodic ataxia.

Arushi Gahlot Saini1, Savita Attri1, N Sankhyan1, Pratibha Singhi1.   

Abstract

Children with citrullinaemia commonly present in the neonatal period with life-threatening hyperammonaemia and progressive encephalopathy. Less often, 'hypomorphic' or mild late-onset childhood or adult-onset forms may be seen with intermittent neurological symptoms or acute crisis in pregnancy. We describe an 11-year-old boy with late-onset citrullinaemia manifesting as brief episodes of ataxia triggered by minor febrile illnesses, significant citrullinaemia, mild hyperammonaemia, normal neurological examination and mild cerebellar atrophy. Targeted gene sequencing showed a homozygous, missense mutation c.815G>A (p.R272H) in exon 12 of ASS1 gene resulting in the amino acid substitution of histidine for arginine at codon 272. Our case highlights the importance of recognising urea cycle defects as a cause of intermittent neurological symptoms such as ataxia. Type-1 citrullinaemia may remain hypomorphic and needs a high index of suspicion. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Neuro Genetics; Nutrition And Metabolism

Mesh:

Substances:

Year:  2018        PMID: 29695388      PMCID: PMC5926573          DOI: 10.1136/bcr-2017-220193

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Structure of the human argininosuccinate synthetase gene and an improved system for molecular diagnostics in patients with classical and mild citrullinemia.

Authors:  J Häberle; S Pauli; M Linnebank; W J Kleijer; H D Bakker; R J A Wanders; E Harms; H G Koch
Journal:  Hum Genet       Date:  2002-03-01       Impact factor: 4.132

2.  The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemia.

Authors:  David P Dimmock; Pamela Trapane; Annette Feigenbaum; Catherine E Keegan; Stephen Cederbaum; James Gibson; Michael J Gambello; Keith Vaux; Patricia Ward; Gregory M Rice; Jon A Wolff; William E O'Brien; Ping Fang
Journal:  Am J Med Genet A       Date:  2008-11-15       Impact factor: 2.802

3.  Investigation of citrullinemia type I variants by in vitro expression studies.

Authors:  Christoph Berning; Iris Bieger; Silke Pauli; Tim Vermeulen; Thomas Vogl; Till Rummel; Wolfgang Höhne; Hans Georg Koch; Boris Rolinski; Klaus Gempel; Johannes Häberle
Journal:  Hum Mutat       Date:  2008-10       Impact factor: 4.878

4.  Metabolic investigations prevent liver transplantation in two young children with citrullinemia type I.

Authors:  Martijn J de Groot; Marcel Cuppen; Marc Eling; Frans W Verheijen; Edmond H H M Rings; Dirk-Jan Reijngoud; Maaike M C de Vries; Francjan J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

  4 in total
  4 in total

Review 1.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 2.  A Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders.

Authors:  Juan Darío Ortigoza-Escobar
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

3.  Hyperammonemic Encephalopathy in an Adolescent Patient of Citrullinemia Type 1 With an Atypical Presentation.

Authors:  Samir Ruxmohan; Jonathan Quinonez; Jinal Choudhari; Sujan Poudel; Krunal Pandav
Journal:  Cureus       Date:  2021-05-19

Review 4.  Episodic Ataxias: Faux or Real?

Authors:  Paola Giunti; Elide Mantuano; Marina Frontali
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.